Guardant Health vs Healthequity
Healthequity is the larger business, with $1.31bn of revenue in fiscal 2026 against $982m for Guardant Health (1.3 times as much). Guardant Health grew faster (32.9% against 9.5%). Healthequity kept more of each dollar of sales as profit: a net margin of 16.4% against -42.4%.
| Latest fiscal year | Guardant HealthGH, 2025 | HealthequityHQY, 2026 |
|---|---|---|
| Revenue | $982m | $1.31bn |
| Revenue growth | 32.9% | 9.5% |
| Net income | −$416m | $215m |
| Operating margin | -44.5% | 24.6% |
| Net margin | -42.4% | 16.4% |
| Return on equity | — | 10.2% |
| Free cash flow | −$233m | $455m |
| Cash | $378m | $319m |
| Total debt | $1.50bn | $957m |
| Debt to equity | — | 45.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $45.0m | $299m |
| Employees | 2,506 | 2,814 |
| Market value | $23.34bn | $8.52bn |
| Price vs our value range | — | Within our value range |
| Moat score | 8 (Weak) | 64 (Moderate) |
| Insider trades, 12 months | 1 buys, 141 sales | 2 buys, 13 sales |